Private Capital Management (Colorado)’s Aratana Therapeutics, Inc. PETX Stock Holding History

Private Capital Management (Colorado)’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,000	Closed	-$62K	–	105
2019 Q2	$62K	Hold	12,000	–	–	0.04%	97
2019 Q1	$43K	Hold	12,000	–	–	0.03%	96
2018 Q4	$74K	Buy	+12,000	New	+$73.2K	0.06%	79

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Private Capital Management (Colorado)'s PETX Position: Q3 2019 in Review

Private Capital Management (Colorado) sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 12,000 shares — an estimated $62K sold.

Private Capital Management (Colorado) first reported a position in PETX in Q4 2018 and held it in 3 quarters. The position peaked at $74K in Q4 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Private Capital Management (Colorado) reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Private Capital Management (Colorado) sold 12,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $62K.
Private Capital Management (Colorado) first reported a position in Aratana Therapeutics, Inc. in Q4 2018 and held it in 3 quarters.
Private Capital Management (Colorado)'s Aratana Therapeutics, Inc. position peaked at $74K in Q4 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Private Capital Management (Colorado)'s 13F filing for Q3 2019, filed 16 Oct 2019.